Skip to main content

Voyager Therapeutics, Inc.

VYGR
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001640266

No open-market purchases or sales by Voyager Therapeutics, Inc. insiders were filed in the last 90 days; 135 institutions reported holding it in 13F filings for Q2 2026, worth $122.7M in total; no superinvestor holds it.

13F holders, Q2 2026

Institutional positions in Voyager Therapeutics, Inc. as of Jun 30, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
135
+2 vs. Q1 2026
Shares held
35.0M
+1.54M (+4.6%) vs. Q1 2026
Total value
$122.7M
−$6.64M (−5.1%) vs. Q1 2026
New holders
18
58 more added
Sold out
16
34 more reduced

2 institutions that held it in Q1 2026 haven't filed for Q2 2026 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q1 2026: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting VYGR on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ2 2026: 135 institutions
Q1 2021: 101 institutionsQ2 2021: 78 institutionsQ3 2021: 69 institutionsQ4 2021: 59 institutionsQ1 2022: 70 institutionsQ2 2022: 78 institutionsQ3 2022: 69 institutionsQ4 2022: 70 institutionsQ1 2023: 82 institutionsQ2 2023: 106 institutionsQ3 2023: 111 institutionsQ4 2023: 107 institutionsQ1 2024: 132 institutionsQ2 2024: 127 institutionsQ3 2024: 128 institutionsQ4 2024: 133 institutionsQ1 2025: 116 institutionsQ2 2025: 113 institutionsQ3 2025: 117 institutionsQ4 2025: 125 institutionsQ1 2026: 135 institutionsQ2 2026: 135 institutions
Value heldQ2 2026: $122.7M
Q1 2021: $125.7MQ2 2021: $96.8MQ3 2021: $58.6MQ4 2021: $51.3MQ1 2022: $171.3MQ2 2022: $142.3MQ3 2022: $142.9MQ4 2022: $146.2MQ1 2023: $183.8MQ2 2023: $307.7MQ3 2023: $211.2MQ4 2023: $227.5MQ1 2024: $331.1MQ2 2024: $301.6MQ3 2024: $205.9MQ4 2024: $196.2MQ1 2025: $117.4MQ2 2025: $103.1MQ3 2025: $141.1MQ4 2025: $132.6MQ1 2026: $129.4MQ2 2026: $122.7M
Institutions holding VYGR and their total value by quarter
QuarterHoldersValue
Q2 2026135$122.7M
Q1 2026135$129.4M
Q4 2025125$132.6M
Q3 2025117$141.1M
Q2 2025113$103.1M
Q1 2025116$117.4M
Q4 2024133$196.2M
Q3 2024128$205.9M
Q2 2024127$301.6M
Q1 2024132$331.1M
Q4 2023107$227.5M
Q3 2023111$211.2M
Q2 2023106$307.7M
Q1 202382$183.8M
Q4 202270$146.2M
Q3 202269$142.9M
Q2 202278$142.3M
Q1 202270$171.3M
Q4 202159$51.3M
Q3 202169$58.6M
Q2 202178$96.8M
Q1 2021101$125.7M

Institutions, Q2 2026

Shares, value and share of portfolio for each institution holding Voyager Therapeutics, Inc.; share changes are against Q1 2026.

Institutions holding VYGR in Q2 2026
InstitutionSharesValue% of portfolioChange in sharesAction
D. E. Shaw & Co., Inc.143,992$504.0K0.00%+45,276+45.9%Added
Bank of New York Mellon Corp146,556$512.9K0.00%+6,786+4.9%Added
American Century Companies Inc146,874$514.1K0.00%−773−0.5%Reduced
Charles Schwab Investment Management Inc151,451$530.1K0.00%+26,338+21.1%Added
Price T Rowe Associates Inc155,526$545.0K0.00%+38,448+32.8%Added
FMR LLC175,868$615.5K0.00%+12,186+7.4%Added
Qube Research & Technologies Ltd194,049$679.2K0.00%+176,544+1,008.5%Added
Invesco Ltd.212,349$743.2K0.00%+93,178+78.2%Added
Seven Fleet Capital Management LP230,406$771.9K0.13%+115,203+100.0%Added
Panagora Asset Management Inc231,077$808.8K0.00%+231,077New
Point72 Asset Management, L.P.236,083$826.3K0.00%−32,140−12.0%Reduced
JPMorgan Chase & Co276,211$988.8K0.00%−656−0.2%Reduced
Fiduciary Trust Co334,397$1.17M0.01%00.0%Unchanged
Vanguard Fiduciary Trust Co337,325$1.18M0.00%+39,003+13.1%Added
Goldman Sachs Group Inc338,477$1.18M0.00%−89,120−20.8%Reduced
AQR Capital Management LLC356,109$1.25M0.00%+123,428+53.0%Added
Northern Trust Corp411,803$1.44M0.00%+26,960+7.0%Added
Diadema Partners LP413,642$1.45M0.51%−10,000−2.4%Reduced
Acadian Asset Management LLC428,670$1.50M0.00%+179,799+72.2%Added
Sphera Funds Management Ltd.427,554$1.50M0.21%−42,207−9.0%Reduced
Renaissance Technologies LLC495,236$1.73M0.00%−82,788−14.3%Reduced
Erste Asset Management GmbH638,900$2.29M0.02%−456,241−41.7%Reduced
Morgan Stanley697,334$2.44M0.00%+15,623+2.3%Added
Citadel Advisors LLC784,067$2.74M0.00%+419,403+115.0%Added
Vanguard Portfolio Management LLC810,091$2.84M0.00%+84,322+11.6%Added
Dimensional Fund Advisors LP838,184$2.93M0.00%−37,384−4.3%Reduced
Two Sigma Investments, LP948,517$3.32M0.00%+332,857+54.1%Added
State Street Corp1,076,422$3.77M0.00%+128,196+13.5%Added
Opaleye Management Inc.1,185,000$4.15M0.38%+35,000+3.0%Added
Geode Capital Management, LLC1,330,492$4.66M0.00%+280,514+26.7%Added
Vanguard Capital Management LLC2,345,674$8.21M0.00%+62,421+2.7%Added
Vestal Point Capital, LP2,625,000$9.19M0.21%−377,936−12.6%Reduced
Armistice Capital, LLC3,436,000$12.0M0.33%−64,000−1.8%Reduced
Millennium Management LLC4,442,951$15.6M0.01%+1,014,380+29.6%Added
BlackRock, Inc.5,172,063$18.1M0.00%−396,318−7.1%Reduced
Woodline Partners LP0$00.00%−193,984−100.0%Sold out
Hudson Bay Capital Management LP0$00.00%−156,250−100.0%Sold out
STRS Ohio0$00.00%−38,000−100.0%Sold out
Quantinno Capital Management LP0$00.00%−35,703−100.0%Sold out
Simplex Trading, LLC0$00.00%−22,261−100.0%Sold out
Chase Investment Counsel Corp0$00.00%−19,800−100.0%Sold out
nVerses Capital, LLC0$00.00%−12,631−100.0%Sold out
Brevan Howard Capital Management LP0$00.00%−11,365−100.0%Sold out
CIBC Asset Management Inc0$00.00%−11,335−100.0%Sold out
Cypress Point Wealth Management, LLC0$00.00%−10,235−100.0%Sold out
Wall Street Financial Group, Inc.0$00.00%−996−100.0%Sold out
Versant Capital Management, Inc0$00.00%−617−100.0%Sold out
CoreCap Advisors, LLC0$00.00%−550−100.0%Sold out
Steward Partners Investment Advisory, LLC0$00.00%−400−100.0%Sold out
Truvestments Capital LLC0$00.00%−330−100.0%Sold out
MAI Capital Management0$00.00%−29−100.0%Sold out
CWM, LLC––––Not filed
Sunbelt Securities, Inc.––––Not filed